MMPW
ABBV icon

Mitchell McLeod Pugh & Williams’s AbbVie ABBV Stock Holding History

Mitchell McLeod Pugh & Williams’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.09M Buy
20,243
+2,887
+17% +$621K 0.63% 31
2026
Q1 		$3.77M Sell
17,356
-10
-0.1% -$2.22K 0.56% 34
2025
Q4 		$3.88M Buy
17,366
+2,199
+14% +$501K 0.55% 34
2025
Q3 		$3.45M Buy
15,167
+327
+2% +$66.6K 0.56% 35
2025
Q2 		$2.75M Sell
14,840
-643
-4% -$120K 0.51% 40
2025
Q1 		$3.24M Buy
15,483
+130
+0.8% +$25.3K 0.67% 30
2024
Q4 		$2.73M Sell
15,353
-633
-4% -$116K 0.57% 38
2024
Q3 		$3.16M Buy
15,986
+27
+0.2% +$5.04K 0.66% 30
2024
Q2 		$2.74M Buy
15,959
+1
+0% +$166 0.62% 35
2024
Q1 		$2.91M Sell
15,958
-438
-3% -$75.5K 0.7% 30
2023
Q4 		$2.54M Sell
16,396
-123
-0.7% -$17.9K 0.67% 32
2023
Q3 		$2.46M Buy
16,519
+382
+2% +$56.1K 0.73% 31
2023
Q2 		$2.17M Buy
16,137
+401
+3% +$58.8K 0.63% 36
2023
Q1 		$2.51M Buy
15,736
+10
+0.1% +$1.53K 0.78% 27
2022
Q4 		$2.54M Sell
15,726
-564
-3% -$86.5K 0.86% 24
2022
Q3 		$2.19M Buy
16,290
+628
+4% +$90.1K 0.84% 24
2022
Q2 		$2.4M Sell
15,662
-616
-4% -$94.1K 0.93% 22
2022
Q1 		$2.64M Sell
16,278
-35
-0.2% -$5.08K 0.89% 23
2021
Q4 		$2.21M Buy
16,313
+71
+0.4% +$8.39K 0.73% 34
2021
Q3 		$1.75M Buy
16,242
+201
+1% +$23K 0.65% 38
2021
Q2 		$1.81M Buy
16,041
+80
+0.5% +$9.01K 0.69% 38
2021
Q1 		$1.73M Buy
15,961
+273
+2% +$29.2K 0.72% 38
2020
Q4 		$1.68M Buy
15,688
+302
+2% +$29K 0.77% 31
2020
Q3 		$1.35M Buy
15,386
+26
+0.2% +$2.45K 0.69% 37
2020
Q2 		$1.51M Buy
15,360
+4,685
+44% +$412K 0.86% 31
2020
Q1 		$813K Buy
10,675
+271
+3% +$23.1K 0.63% 49
2019
Q4 		$922K Sell
10,404
-487
-4% -$40.4K 0.58% 55
2019
Q3 		$825K Buy
10,891
+1
+0% +$69 0.56% 61
2019
Q2 		$792K Buy
10,890
+176
+2% +$13.8K 0.54% 64
2019
Q1 		$864K Buy
10,714
+185
+2% +$15.1K 0.6% 58
2018
Q4 		$971K Buy
10,529
+1
+0% +$88 0.78% 37
2018
Q3 		$996K Buy
10,528
+15
+0.1% +$1.42K 0.67% 44
2018
Q2 		$974K Buy
10,513
+100
+1% +$9.77K 0.69% 42
2018
Q1 		$985K Sell
10,413
-207
-2% -$22.7K 0.71% 41
2017
Q4 		$1.03M Buy
10,620
+193
+2% +$18.2K 0.71% 42
2017
Q3 		$926K Hold
10,427
– – 0.68% 50
2017
Q2 		$756K Buy
10,427
+2
+0% +$134 0.57% 68
2017
Q1 		$679K Buy
10,425
+79
+0.8% +$4.97K 0.53% 70
2016
Q4 		$648K Buy
10,346
+501
+5% +$30.6K 0.52% 69
2016
Q3 		$621K Buy
9,845
+3
+0% +$194 0.54% 70
2016
Q2 		$609K Buy
9,842
+1,202
+14% +$73.2K 0.55% 65
2016
Q1 		$494K Sell
8,640
-250
-3% -$13.9K 0.48% 75
2015
Q4 		$527K Buy
8,890
+1
+0% +$58 0.52% 69
2015
Q3 		$483K Sell
8,889
-260
-3% -$16.9K 0.5% 75
2015
Q2 		$615K Sell
9,149
-112
-1% -$7.31K 0.57% 64
2015
Q1 		$542K Buy
9,261
+119
+1% +$7.19K 0.49% 77
2014
Q4 		$598K Buy
+9,142
New +$576K 0.55% 65

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mitchell McLeod Pugh & Williams's ABBV Position: Q2 2026 in Review

Mitchell McLeod Pugh & Williams increased its AbbVie (ABBV) stake by 17% in Q2 2026, buying an estimated $621K and bringing the position to 20,243 shares worth $5.09M. The position accounts for 0.63% of the portfolio, ranked #31.

Mitchell McLeod Pugh & Williams first reported a position in ABBV in Q4 2014 and has held it in 47 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Mitchell McLeod Pugh & Williams held 20,243 shares of AbbVie worth $5.09M as of Q2 2026.
  • Mitchell McLeod Pugh & Williams bought 2,887 AbbVie shares in Q2 2026, an estimated $621K.
  • AbbVie made up 0.63% of Mitchell McLeod Pugh & Williams's portfolio in Q2 2026, its #31 holding.
  • Mitchell McLeod Pugh & Williams first reported a position in AbbVie in Q4 2014 and has held it in 47 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mitchell McLeod Pugh & Williams's 13F filing for Q2 2026, filed 11 Aug 2026.